Table 1.

Clinical and Laboratory Findings for Each TAMOF Patient (n=12)

Ca., cancer; DM, Diabetes mellitus; PE, plasma exchange; % micro, % microcytes; % hyper, % hyperchromic red cells; RDW, red cell distribution width; HDW, hemoglobin distribution width; RBC, red blood cell; MC, manual counting; PT, prothrombin time; aPTT, activated partial thromboplastin time; LDH, lactate dehydrogenase; SOFA, sequential organ failure assessment; DIC, disseminated intravascular coagulation; TAMOF, thrombocytopenia-associated multiple organ failure; TMA, thrombotic microangiopathy; NA, not assessed.